Immunology Practice Questions

Q: The process by which antigen-specific B lymphocytes are selected and activated to proliferate and produce antibodies is called:

Clonal selection. ***Clonal selection*** - **Clonal selection** is the fundamental process by which an antigen-specific B lymphocyte is **selected** when its B cell receptor (BCR) recognizes and binds to a matching antigen. - This binding triggers the B cell to become **activated**, **proliferate** (undergo clonal expansion), and **differentiate** into plasma cells that produce antibodies specific to that antigen. - This process is the cornerstone of **adaptive immunity**, ensuring that only B cells with receptors matching the encountered antigen are stimulated to respond. *Class switching* - **Class switching** (isotype switching) occurs AFTER clonal selection and activation. - It allows already-activated B cells to change the **antibody class** they produce (from IgM to IgG, IgA, or IgE) while maintaining the **same antigen specificity**. - This process modifies effector functions but does NOT involve the initial selection and activation of antigen-specific B cells. *Group switching* - This is not a recognized term in immunology. - It does not describe any standard process of B cell activation or antibody production. *Hybridisation* - **Hybridization** refers to the formation of double-stranded nucleic acids from complementary strands or the creation of hybrid cells (e.g., hybridomas for monoclonal antibody production). - It is not the physiological process by which B lymphocytes are selected and activated in response to antigen exposure.

Q: IFN-gamma is produced by

T-cells. ***T-cells*** - **Interferon-gamma (IFN-γ)** is a crucial cytokine primarily produced by **activated T-lymphocytes**, especially **Th1 cells** and **cytotoxic T lymphocytes (CTLs)**. - Natural killer (NK) cells also produce **IFN-γ**, which plays a key role in **antiviral** and **antitumor immunity**, as well as in promoting **Type 1 immune responses**. *Macrophages* - While macrophages are **responsive to IFN-γ** (e.g., becoming activated), they are not the primary producers of this cytokine. - Macrophages primarily produce other cytokines such as **IL-1, IL-6, TNF-alpha**, and **IL-12** in response to infection or inflammation. *Neutrophils* - **Neutrophils** are key phagocytes in the innate immune system and are primarily involved in engulfing and killing pathogens. - They are not known to be a significant source of **IFN-γ** production; their main defensive mechanisms involve **phagocytosis**, **degranulation**, and **NETosis**. *B-cells* - **B-cells** are central to humoral immunity, specializing in **antibody production** and acting as **antigen-presenting cells**. - They generally do not produce **IFN-γ**; instead, their cytokine repertoire includes **IL-10**, **IL-6**, and **lymphotoxin**.

Q: What are the changes in the variable region of immunoglobulins?

Idiotype. ***Idiotype*** - **Idiotype** refers to the unique set of antigenic determinants in the **variable region** of an antibody molecule, specifically within the **hypervariable regions (complementarity-determining regions, CDRs)**. - These unique determinants allow antibodies to recognize specific antigens and are generated by the specific **V(D)J gene rearrangements** in B cells. *Isotype* - **Isotype** refers to the constant region of an antibody, determining its class (e.g., **IgG, IgM, IgA, IgD, IgE**). - This region defines the antibody's effector functions and has nothing to do with the antigen-binding variability. *Allotype* - **Allotype** refers to minor genetic variations within the **constant region** of an antibody molecule within a species. - These variations are due to different alleles inherited from parents and are not associated with the variable region that binds to antigens. *Epitope* - An **epitope** is the specific part of an **antigen** that an antibody or T-cell receptor recognizes and binds to. - It is a feature of the antigen, not a change within the variable region of the immunoglobulin itself.

Q: Rosette formation with sheep RBCs (SRBCs) indicates functioning of -

T-cells. ***T-cells*** - **T-cells** possess specific receptors, like **CD2** on their surface, that can bind to ligands on sheep red blood cells (SRBCs). - This binding leads to the formation of characteristic **rosettes**, where SRBCs cluster around the T-lymphocytes, indicating functional T-cells. *B-cells* - **B-cells** primarily function in **humoral immunity** by producing antibodies and do not typically form rosettes with sheep RBCs. - While B-cells have surface receptors, they are not CD2 and thus do not facilitate this specific type of rosette formation. *Neutrophils* - **Neutrophils** are **phagocytic cells** involved in innate immunity, primarily combating bacterial and fungal infections. - They lack the specific surface receptors (like CD2) required to form rosettes with sheep RBCs. *Monocytes* - **Monocytes** are precursors to macrophages and dendritic cells, involved in phagocytosis and antigen presentation. - They do not possess the necessary surface markers to form rosettes with sheep RBCs.

Q: Which immunoglobulin is known to be heat-labile?

IgM. ***IgM*** - **IgM** is known for its **heat lability** and is readily denatured at 56°C within a few minutes. - This characteristic is due to its **pentameric structure** held together by disulfide bonds and J chains, which are sensitive to thermal denaturation. - Heat lability of IgM is clinically important in complement fixation tests and other laboratory assays where heat inactivation is performed. - IgM is the first antibody produced in primary immune response and its heat sensitivity distinguishes it from other immunoglobulins. *IgA* - **IgA** exists in monomeric (serum) and dimeric (secretory) forms and shows moderate stability to heat. - Secretory IgA is relatively stable as it needs to function in harsh mucosal environments, though not as heat-resistant as IgG. - Does not exhibit the pronounced heat lability characteristic of IgM. *IgG* - **IgG** is the most stable immunoglobulin and is highly resistant to heat denaturation. - Can withstand temperatures up to 60-70°C without significant loss of activity. - Its monomeric structure with strong intramolecular bonds provides exceptional thermal stability. - Most abundant antibody in serum and has the longest half-life. *IgE* - **IgE** is actually quite stable to heat and can withstand 56°C for extended periods. - While it has a short half-life in serum (2-3 days), this is due to receptor binding rather than heat instability. - Important in type I hypersensitivity reactions and parasitic infections. - Does not show the characteristic heat lability that defines IgM.

Q: What is the primary use of the Hybridoma technique?

Monoclonal antibodies. ***Monoclonal antibodies*** - The **hybridoma technique** is primarily used to produce **monoclonal antibodies (MAbs)**, which are highly specific antibodies derived from a single B-cell clone. - These antibodies recognize a **single epitope** on an antigen, providing exceptional specificity and uniformity. - The technique involves **fusing a B-lymphocyte** (antibody-producing cell) with a **myeloma cell** (immortal cancer cell) to create a hybridoma that continuously produces identical antibodies. - This is the **gold standard** for producing large quantities of identical, highly specific antibodies for diagnostic and therapeutic use. *Specific antibodies* - While monoclonal antibodies are indeed specific, this term is **too vague** and could refer to any antibody with specificity, including polyclonal antibodies. - **Polyclonal antibodies** are also specific but are produced through conventional immunization, not the hybridoma technique. - The defining characteristic of the hybridoma technique is that it produces **monoclonal** (single clone) antibodies, not just "specific" ones. *Antigen* - An **antigen** is a molecule that elicits an immune response and is used to immunize animals during antibody production. - However, antigens are the **input** for antibody production, not the **product** of the hybridoma technique. *Cytokines* - **Cytokines** are signaling molecules involved in immune cell communication and regulation. - They are not produced by the hybridoma technique, which is specifically designed for **antibody production**.

Q: Cytolytic activity of membrane attack complex is modulated by ?

Factor S (vitronectin). ***Correct Option: Factor S (vitronectin)*** - Vitronectin (S-protein) is a **plasma protein** that directly modulates the **cytolytic activity of the membrane attack complex (MAC)**. - It binds to the **C5b-7 complex** in the fluid phase, preventing its insertion into target cell membranes and thereby blocking the formation of the complete, functional MAC. - By inhibiting membrane insertion of C5b-7, vitronectin prevents the subsequent binding of **C8 and C9**, which are essential for the cytolytic pore formation. - This is a **direct modulation** of MAC's cytolytic activity at the MAC assembly stage. *Incorrect Option: Factor H* - Factor H is a regulatory protein that controls the **alternative pathway** of complement activation by promoting degradation of **C3b**. - By degrading C3b, Factor H prevents formation of **C5 convertase**, thereby reducing downstream MAC formation. - However, Factor H acts **early in the complement cascade** and does not directly modulate the cytolytic activity of already-formed MAC components. - Its effect is on **preventing MAC formation**, not on modulating MAC's cytolytic function itself. *Incorrect Option: Factor I* - Factor I is a **serine protease** that cleaves and inactivates C3b and C4b, requiring cofactors like Factor H or C4bp. - Like Factor H, it regulates complement activation **upstream** of MAC formation. - It does not directly interact with or modulate the cytolytic activity of the MAC. *Incorrect Option: Factor B* - Factor B is a component of the **alternative pathway C3 convertase** (C3bBb). - It **promotes complement activation** rather than modulating MAC's cytolytic activity. - Factor B functions early in the cascade and has no direct role in regulating MAC function.

Q: What is the most common genetic factor associated with increased susceptibility to Neisseria infections?

Complement deficiency. ***Complement deficiency*** - Deficiencies in the **terminal complement pathway (C5-C9)**, particularly C5b-C9 (membrane attack complex, MAC), significantly increase susceptibility to disseminated *Neisseria* infections. - The MAC is crucial for lysing Gram-negative bacteria like *Neisseria meningitidis* and *Neisseria gonorrhoeae*, and its absence allows for uncontrolled bacterial proliferation. *Factor H deficiency* - **Factor H** is a regulatory protein of the alternative complement pathway, preventing its overactivation on host cells. - Its deficiency typically leads to conditions like **atypical hemolytic uremic syndrome (aHUS)** and **dense deposit disease**, not primarily increased susceptibility to *Neisseria* infections. *HLA B27* - **HLA-B27** is a human leukocyte antigen strongly associated with a group of autoimmune inflammatory diseases called **spondyloarthropathies**, such as ankylosing spondylitis. - It does not directly impact the immune response to *Neisseria* infections or increase susceptibility to them. *IgA deficiency* - **Selective IgA deficiency** is the most common primary immunodeficiency, characterized by low or absent IgA levels. - Individuals with IgA deficiency are more prone to **recurrent respiratory and gastrointestinal infections**, but not specifically disseminated *Neisseria* infections.

Q: Which immunoglobulin is primarily secreted by the intestine?

IgA. **IgA** - **Secretory IgA** is the dominant immunoglobulin in mucosal secretions, including those of the intestine. - It plays a crucial role in providing **local immunity** by preventing microbial adherence and neutralizing toxins on mucosal surfaces. *IgG* - **IgG** is the most abundant immunoglobulin in serum and plays a major role in systemic immunity, including opsonization and complement activation. - While some IgG is found in secretions, it is not the primary immunoglobulin secreted by the intestine. *IgM* - **IgM** is a pentameric immunoglobulin, primarily found in blood and lymph, where it is very effective in activating the complement system and agglutinating antigens. - Although it can be found at mucosal surfaces in small amounts, it is not the principal secreted antibody in the intestine. *IgD* - **IgD** is primarily found on the surface of naive B lymphocytes, where it functions as a B cell receptor. - Its role in secreted form is minimal, and it is not significantly secreted into the intestine or other bodily fluids.

Q: Which of the following is a superantigen ?

TSST. ***TSST*** - **Toxic Shock Syndrome Toxin-1 (TSST-1)** is a classic example of a superantigen produced by *Staphylococcus aureus*. - Superantigens **bind directly to MHC class II molecules and T-cell receptors (TCRs)** outside of the antigen-binding groove, leading to non-specific activation of a large percentage of T cells and a massive release of cytokines. *Cholera toxin* - **Cholera toxin** is an exotoxin produced by *Vibrio cholerae* that causes massive fluid secretion in the intestine by **activating adenylate cyclase** in enterocytes. - It functions by **ADP-ribosylating the Gs alpha subunit**, leading to constitutive activation of cyclic AMP production, but it is not a superantigen. *Diphtheria toxin* - **Diphtheria toxin**, produced by *Corynebacterium diphtheriae*, inhibits protein synthesis in eukaryotic cells by **ADP-ribosylating elongation factor-2 (EF-2)**. - This action leads to cell death and the characteristic pseudomembrane formation in diphtheria, but it does not act as a superantigen. *Vero-cytoxin* - **Vero-cytoxin** (also known as Shiga toxin or Shiga-like toxin) is produced by *E. coli* O157:H7 and other Shiga toxin-producing *E. coli* (STEC). - It inhibits protein synthesis by **cleaving ribosomal RNA**, primarily causing damage to intestinal cells and renal endothelial cells, but it is not a superantigen.

Question 1

The process by which antigen-specific B lymphocytes are selected and activated to proliferate and produce antibodies is called:

Accepted Answer

Clonal selection

Answer

Class switching

Answer

Group switching

Answer

Hybridisation

Question 2

IFN-gamma is produced by

Accepted Answer

T-cells

Answer

Macrophages

Answer

Neutrophils

Answer

B-cells

Question 3

What are the changes in the variable region of immunoglobulins?

Accepted Answer

Idiotype

Answer

Isotype

Answer

Epitope

Answer

Allotype

Question 4

Rosette formation with sheep RBCs (SRBCs) indicates functioning of -

Accepted Answer

T-cells

Answer

B-cells

Answer

Neutrophils

Answer

Monocytes

Question 5

Which immunoglobulin is known to be heat-labile?

Accepted Answer

IgM

Answer

IgA

Answer

IgG

Answer

IgE

Question 6

What is the primary use of the Hybridoma technique?

Accepted Answer

Monoclonal antibodies

Answer

Antigen

Answer

Specific antibodies

Answer

Cytokines

Question 7

Cytolytic activity of membrane attack complex is modulated by ?

Accepted Answer

Factor S (vitronectin)

Answer

Factor I

Answer

Factor B

Answer

Factor H

Question 8

What is the most common genetic factor associated with increased susceptibility to Neisseria infections?

Accepted Answer

Complement deficiency

Answer

HLA-B27

Answer

IgA deficiency

Answer

Factor H deficiency

Question 9

Which immunoglobulin is primarily secreted by the intestine?

Accepted Answer

IgA

Answer

IgG

Answer

IgM

Answer

IgD

Question 10

Which of the following is a superantigen ?

Accepted Answer

TSST

Answer

Cholera toxin

Answer

Diphtheria toxin

Answer

Vero-cytoxin

Immunology — MCQs

Immunology — MCQs

On this page

Practice by Chapter

Want unlimited practice?